GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Wuhan Hvsen Biotechnology Co Ltd (SZSE:300871) » Definitions » Current Deferred Revenue

Wuhan Hvsen Biotechnology Co (SZSE:300871) Current Deferred Revenue : ¥0 Mil (As of Sep. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Wuhan Hvsen Biotechnology Co Current Deferred Revenue?

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Wuhan Hvsen Biotechnology Co's current deferred revenue for the quarter that ended in Sep. 2024 was ¥0 Mil.

Wuhan Hvsen Biotechnology Co Current Deferred Revenue Historical Data

The historical data trend for Wuhan Hvsen Biotechnology Co's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wuhan Hvsen Biotechnology Co Current Deferred Revenue Chart

Wuhan Hvsen Biotechnology Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Current Deferred Revenue
Get a 7-Day Free Trial - - - - -

Wuhan Hvsen Biotechnology Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Current Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Wuhan Hvsen Biotechnology Co Current Deferred Revenue Related Terms

Thank you for viewing the detailed overview of Wuhan Hvsen Biotechnology Co's Current Deferred Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Wuhan Hvsen Biotechnology Co Business Description

Traded in Other Exchanges
N/A
Address
218 Zhangbai Road, Dongxihu District, Hubei Province, Wuhan, CHN, 430042
Wuhan Hvsen Biotechnology Co Ltd is engaged in research and development, production and sales of veterinary drugs (including chemical drug preparations, raw materials, and Chinese medicine preparations), feed and additives. It produces tylvalosin raw material, various tylvalosin preparations, florfenicol preparations and other macrolides products.

Wuhan Hvsen Biotechnology Co Headlines

No Headlines